Citation Impact
Citing Papers
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration
2008
A systematic review of evidence on the links between patient experience and clinical safety and effectiveness
2013 Standout
Pharmacokinetics of Once-Daily Saquinavir Hard-Gelatin Capsules and Saquinavir Soft-Gelatin Capsules Boosted With Ritonavir in HIV-1–Infected Subjects
2003
Adverse effects of antiretroviral therapy for HIV infection: a review of selected topics
2005
A new taxonomy for describing and defining adherence to medications
2012 Standout
Factor structure and validity of the Medication Adherence Questionnaire (MAQ) with cigarette smokers trying to quit
2007
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status
2020 Standout
Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs
2004 Standout
Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: a randomized clinical trial
2010 StandoutNobel
The Effectiveness of Mobile-Health Technology-Based Health Behaviour Change or Disease Management Interventions for Health Care Consumers: A Systematic Review
2013 Standout
A Once-Daily Lopinavir/Ritonavir-Based Regimen Is Noninferior to Twice-Daily Dosing and Results in Similar Safety and Tolerability in Antiretroviral-Naive Subjects Through 48 Weeks
2009
Antiretroviral Therapy for HIV Infection
1998
Association of abacavir and impaired endothelial function in treated and suppressed HIV-infected patients
2009
Better Adherence with Once‐Daily Antiretroviral Regimens: A Meta‐Analysis
2009
Lipodystrophy Syndromes
2008
Switching from twice‐daily abacavir and lamivudine to the once‐daily fixed‐dose combination tablet of abacavir and lamivudine improves patient adherence and satisfaction with therapy
2008
The Impact of Once-Nightly Versus Twice-Daily Dosing and Baseline Beliefs About HAART on Adherence to Efavirenz-Based HAART Over 48 Weeks: The NOCTE Study
2010
Dynamics and functions of lipid droplets
2018 Standout
Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation
2004 Standout
The end of AIDS: HIV infection as a chronic disease
2013 Standout
Clinical Pharmacokinetics and Summary of Efficacy and Tolerability of Atazanavir
2005
Management of the metabolic effects of HIV and HIV drugs
2011
Ultra-potent P1 modified arylsulfonamide HIV protease inhibitors: The discovery of GW0385
2006
Lopinavir/Ritonavir
2003
Identification and Assessment of Adherence-Enhancing Interventions in Studies Assessing Medication Adherence Through Electronically Compiled Drug Dosing Histories: A Systematic Literature Review and Meta-Analysis
2013
Functional Genomic Analysis of C. elegans Molting
2005 StandoutNobel
Impact of treatment with raltegravir during primary or chronic HIV infection on RNA decay characteristics and the HIV viral reservoir
2011 StandoutNobel
Expanding clinical applications of population pharmacodynamic modelling
1998
Effect of twice-daily nevirapine on adherence in HIV-1-infected patients: a randomized controlled study
2007
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
2009 Standout
Update on Key Emerging Challenges in Cystic Fibrosis
2014 Standout
Inhibition of HIV replication: A powerful antiviral strategy by IFN-β gene delivery in CD4+ cells
2007 StandoutNobel
Medication Adherence: WHO Cares?
2011 Standout
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Knowledge translation of research findings
2012 Standout
Copper-Mediated Coupling Reactions and Their Applications in Natural Products and Designed Biomolecules Synthesis
2008 Standout
Can Treatment Adherence Be Improved by Using Rubin's Four Tendencies Framework to Understand a Patient's Response to Expectations
2017 Standout
Continued Production of Drug-Sensitive Human Immunodeficiency Virus Type 1 in Children on Combination Antiretroviral Therapy Who Have Undetectable Viral Loads
2003
Interventions for enhancing medication adherence
2008 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Interventions for enhancing medication adherence
2014 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Medication Adherence
2009 Standout
Medication Adherence Measures: An Overview
2015 Standout
Works of GJ Moyle being referenced
Individualisation of HIV therapy: the clinician's perspective.
1995
INDIVIDUALISATION OF HIV THERAPY: THE CLINICIAN'S PERSPECTIVE
1995
A randomized open‐label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection
2004
Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone
2005
Long‐term safety and efficacy of poly‐L‐lactic acid in the treatment of HIV‐related facial lipoatrophy
2006
Better maintained adherence on switching from twice‐daily to once‐daily therapy for HIV: a 24‐week randomized trial of treatment simplification using stavudine prolonged‐release capsules
2005
Principles and practice of HIV‐protease inhibitor pharmacoenhancement
2001
The role of stavudine in the management of adults with HIV infection.
1997
The role of didanosine in the management of HIV-1 infection.
1997